XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Share-based Payments | 3 Months Ended
--- | ---
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-based Payments | Note 9 - Share-based Payments On January 23, 2014, upon effectiveness of the registration statement filed with the SEC, the Company adopted the 2013 Stock Incentive Plan (the “Plan”) which will provide for the issuance of up to 400,000 shares. The purpose of the Plan is to provide additional incentive to those officers, employees, consultants and non-employee directors of the Company and its parents, subsidiaries and affiliates whose contributions are essential to the growth and success of the Company’s business. On January 9, 2015, the Board of Directors of the Company approved, upon recommendation from the Compensation Committee of the Board, by unanimous written consent the Amended and Restated 2013 Incentive Stock and Award Plan (the “Amended Plan”), which increases the number of authorized shares of Common Stock subject to the Plan to 800,000 shares (Note 3). On September 30, 2016, the Board of Directors increased the number of authorized shares of Common Stock subject to the Amended Plan to 830,000 shares. As of March 31, 2018, grants of restricted stock and options to purchase 255,000 shares of Common Stock have been issued, pursuant to the Amended Plan, and are unvested or unexercised and 7,292 shares of Common Stock remain available for grants under the Amended Plan. On August 7, 2017, the Shareholders approved and the Company adopted the 2017 Equity Incentive Plan (the “Plan”) which will provide for the issuance of up to 1,350,000 shares. The purpose of the Plan is to provide additional incentive to those officers, employees, consultants and non-employee directors of the Company and its parents, subsidiaries and affiliates whose contributions are essential to the growth and success of the Company’s business. As of March 31, 2018, grants totaling 320,107 shares of restricted Common Stock have been issued pursuant to the Plan and 1,029,893 shares of Common Stock remain available for grants under the Plan. The Plan may be administered by the Board or a Board-appointed committee. Eligible recipients of option awards are employees, officers, consultants or directors (including non-employee directors) of the Company or of any parent, subsidiary or affiliate of the Company. The Board has the authority to grant to any eligible recipient any options, restricted stock or other awards valued in whole or in part by reference to, or otherwise based on, the Company’s Common Stock. Qualified option holders may exercise their options at their discretion. Each option granted may be exchanged for a prescribed number of shares of Common Stock. The Company did not issue any options or warrants under the above plan during the three months ended March 31, 2018. The following table summarizes the option activities for the three months ended March 31, 2018:
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Weighted |  |  | Average |  |  |  |
|  |  |  |  | Average |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  | Intrinsic |
|  | Shares |  |  | Price |  |  | Term (years) |  |  | Value |
Balance at December 31, 2017 |  |  | 255,000 |  |  | $ | 4.25 |  |  |  | 2.02 |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Canceled/Expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Balance at March 31, 2018 |  |  | 255,000 |  |  | $ | 4.25 |  |  |  | 1.78 |  |  | $ | - |
Exercisable as of March 31, 2018 |  |  | 250,334 |  |  | $ | 4.27 |  |  |  | 1.75 |  |  | $ | - |
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.83 for our common shares on March 31, 2018. A summary of the Company’s non-vested shares as of March 31, 2018 and the changes during the three months then ended are as follows:
|  |  |  |  | Weighted |
|  |  |  |  | Average Grant |
Non-Vested Shares |  | Shares |  |  | Date Fair Value |
Non-vested at December 31, 2017 |  |  | 4,666 |  |  | $ | 2.36 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |
Non-vested at March 31, 2018 |  |  | 4,666 |  |  | $ | 2.36 |
Unrecognized compensation cost related to non-vested employee stock options totaled $4,219 as of March 31, 2018. The cost is to be recognized over a weighted average period of 0.38 years. During the three months ended March 31, 2018 and 2017, the Company incurred stock option expenses totaling $2,712 and $5,036. The table below summarizes the warrant activity for the three months ended March 31, 2018:
|  |  |  |  | Weighted |  |  | Average |
|  |  |  |  | Average |  |  | Remaining |
|  | Number of |  |  | Exercise |  |  | Contractual |
|  | Warrants |  |  | Price |  |  | Term (years) |
Balance at December 31, 2017 |  |  | 49,490,571 |  |  | $ | 0.22 |  |  |  | 4.95 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (30,492,070 | ) |  |  | 0.19 |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |
Canceled/Expired |  |  | - |  |  |  | - |  |  |  | - |
Balance at March 31, 2018 |  |  | 18,998,501 |  |  | $ | 0.28 |  |  |  | 4.68 |
Exercisable as of March 31, 2018 |  |  | 18,998,501 |  |  | $ | 0.28 |  |  |  | 4.68 |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration